Metformin reduces overall cancer risk in patients with Type 2 diabetes

[News]

A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.

More... (http://www.news-medical.net/news/20120626/Metformin-reduces-overall-cancer-risk-in-patients-with-Type-2-diabetes.aspx)